Literature DB >> 4952369

A statistical review of malignant testicular tumours based on the experience of the Ontario Cancer Foundation Clinics, 1938-1961.

E N MacKay, A H Sellers.   

Abstract

For the 827 patients with malignant testicular tumours registered at the Ontario Cancer Foundation's regional clinics in the period 1938-1961, the probability of surviving for five years after treatment was 59.8%; for the 731 patients who received all or part of their initial treatment at the clinics or were not treated anywhere, five-year survival probability was 62.7%. Most deaths from testicular cancer took place in the first two years after treatment, and 90% of recorded recurrences were diagnosed before the third anniversary. Survival rates were strongly influenced by histological type and extent of disease, and to some degree by age. Survival did not seem to be closely correlated with delay after first symptom, site or size of primary lesion, ectopia, surgical treatment of the abdominal nodes, site or dosage of radiation, or chemotherapy. The survival rates in this series of cases compare favourably with those of other large series.

Entities:  

Mesh:

Year:  1966        PMID: 4952369      PMCID: PMC1936588     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  2 in total

1.  A simple method for determing standard errors of survival rates, with tables.

Authors:  F EDERER
Journal:  J Chronic Dis       Date:  1960-06

2.  Diagnosis and treatment of testicular tumors.

Authors:  J F PATTON; D N SEITZMAN; R A ZONE
Journal:  Am J Surg       Date:  1960-04       Impact factor: 2.565

  2 in total
  8 in total

1.  Recent trends in mortality due to testicular cancer in Ireland: a comparison with England and Wales.

Authors:  J A Thornhill; R M Conroy; D G Kelly; A Walsh; J J Fennelly; J M Fitzpatrick
Journal:  J Epidemiol Community Health       Date:  1986-09       Impact factor: 3.710

2.  [Testicular neoplasms. Main surgical-urologic lecture].

Authors:  A Sigel
Journal:  Langenbecks Arch Chir       Date:  1968

3.  Referred scrotal pain: case reports and review.

Authors:  S R McGee
Journal:  J Gen Intern Med       Date:  1993-12       Impact factor: 5.128

4.  Comparison of histologic types of primary testicular germ cell tumors with their metastases: consequences for the WHO and the British Nomenclatures?

Authors:  W Bär; C Hedinger
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-04-05

5.  Metastasis of cancer in the cryptorchid testis to the sigmoid colon.

Authors:  A Kwinta; E Lipska-Papeé
Journal:  Int Urol Nephrol       Date:  1983       Impact factor: 2.370

6.  Malignant testicular tumours.

Authors:  P Del Vecchio; E Tawil; G Béland
Journal:  Can Med Assoc J       Date:  1974-01-19       Impact factor: 8.262

7.  Testicular Germ-Cell Tumours: A Descriptive Analysis of Clinical Characteristics at First Presentation.

Authors:  Klaus-Peter Dieckmann; Hanna Richter-Simonsen; Magdalena Kulejewski; Raphael Ikogho; Henrik Zecha; Petra Anheuser; Uwe Pichlmeier; Hendrik Isbarn
Journal:  Urol Int       Date:  2018-04-12       Impact factor: 2.089

8.  Antipyrine metabolism in patients with disseminated testicular cancer and the influence of cytostatic treatment.

Authors:  M W Teunissen; P H Willemse; D T Sleijfer; W J Sluiter; D D Breimer
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.